Cellivia is a biotechnology company specializing in: • cell and tissue bioengineering, biotechnology and biomedicine research - own and commercial projects • development and commercialization of innovative therapies and personalized medicines via exosomes • biological material banking for research purposes • bioengineering and robotics in medicine Our mission is to provide personalized medicines and medical therapies based on exosomes. Cellivia‘s team are high-class specialists, including scientists with the professor title, in the field of dentistry, cellular and molecular biology, biotechnology as well as chemical and material bioengineering. The company cooperates with leading universities and research centers in Europe such as the Poznan Science and Technology Park, the Poznan Medical University, the University Hospital and Masaryk University in Brno, Wielkopolska Center for Advanced Technologies. Cellivia conducts a number of research projects, such as the Oral Biology Project - research on the gum and pulp of human teeth; Animal Biology Project - research on animal material from the mucous membrane; Bioexofold - research on biologically active material for reconstruction and regeneration; Bioactive Abutment - research on functionalized titanium. Research projects are used in implemented therapies. The company also carries out pioneering research on chemical and material bioengineering in cooperation with the Poznan Science and Technology Park. Research includes developing a biologically active coating for use in implantology and prosthetics. We have applied for a patent Our Our innovative solutions are being reviewed by Patent Office Cellivia branches: CelliviaLab - area of research and laboratory activities CelliviaDent - the area of dental activity Cellivia Bank - a bank of stem cells and cell lines run for the needs of applied therapies - during the registration procedure
